ArticleJAMA network open2026

GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk in Nonmalignant Uterine Diseases.

Ting-Tai Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.